Publication Beamlines Strategic Pillar
Bewer, Brian (2020). Comparison of dose values predicted by FLUKA to measured values using Luxel+ Ta type dosimeters. Nuclear Instruments and Methods in Physics Research. Section B: Beam Interactions with Materials and Atoms 464, 12-18. 10.1016/j.nimb.2019.11.042. Materials
Billinghurst, Brant E. (2020). Preface: Special Issue: 10th International Workshop on Infrared Microscopy and Spectroscopy with Accelerator Based Sources (WIRMS 2019). Infrared Physics and Technology 107, 103330. 10.1016/j.infrared.2020.103330. Materials
Garcia-Martin, Susana; King, Graham; Urones-Garrote, Esteban; Woodward, Patrick M. (2021). Coupled Compositional and Displacive Modulations in KLaMnWO6 Revealed by Atomic Resolution Imaging. Journal of the American Chemical Society 143(45) . 10.1021/jacs.1c07426. Materials
Harrison, Kim D; Hiebert, Beverly D; Panahifar, Arash; Andronowski, Janna M; Ashique, Amir M et al. (2020). Cortical Bone Porosity in Rabbit Models of Osteoporosis. Journal of Bone and Mineral Research 35(11) , 2211-2228. 10.1002/jbmr.4124. Health
Patel, Megha; Zhong, Jiayun; Gomez‐Haibach, Konrad S.; Gomez, Maria A.; King, Graham et al. (2020). Low‐energy Sr 2 MSbO 5.5 (M = Ca and Sr) structures show significant distortions near oxygen vacancies. International Journal of Quantum Chemistry 120(20) . 10.1002/qua.26356. Materials
Rakhmatullin, Aydar; Molokeev, Maxim S.; King, Graham; Polovov, Ilya B.; Maksimtsev, Konstantin V. et al. (2021). Polymorphs of Rb3ScF6: X-ray and Neutron Diffraction, Solid-State NMR, and Density Functional Theory Calculations Study. Inorganic Chemistry 60(8) , 6016-6026. 10.1021/acs.inorgchem.1c00485. Materials
Reid, Joel W.; Kaduk, James A. (2021). Crystal structure of donepezil hydrochloride form III, C24H29NO3⋅HCl. Powder Diffraction 36(4) , 233-240. 10.1017/s0885715621000415. Health
(2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: IL279484A.
(2020). Combination of lif inhibitors and pd-1 axis inhibitors for use in treating cancer. Patent Number: IL277918A.
(2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: IL279444A.
(2021). ANTIBODY. Patent Number: PT3311170T.
(2021). MODELING TEST. Patent Number: PT3311169T.
(2021). Stable heterodimeric antibody design with mutations in the fc domain. Patent Number: PT2773671T.
(2020). ANTI-BCMA ANTIBODIES, BIESPECIFIC ANTIGEN BINDING MOLECULES THAT BIND BCMA AND CD3, AND THEIR USES. Patent Number: PT3337824T.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 요한 프란손; 로빈 매튜 할렛; 모니카 파스쿠알 가르시아 et al. (2021). Combination of LIF inhibitor and PD-1 axis inhibitor for use in treating cancer. Patent Number: KR20210021287A.